The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Geeman Happy NY. Wishing this year would be a prosperous one for u. I've also been following AGL for some time. Bought when they got FDA clearance and then sold at a loss soon after when I realised it lost momentum. That was when it was 150p... now it's crazy 27p.. but market cap it around 70mil with 30mil cash in bank so could go down more. No idea where the bottom is... Any thoughts? I am done catching bottoms like I did with Eve sleep.. adjusting my strategy to trying to buy on the way up. Lets see how that works. ONC is also in liquid biopsies too.. except their US distributor is starting to show some legs and a bit of results.
I left Angle a little while ago. it was my intention just to let it sit there and get bought out but as it kept falling I decided it was getting too risky.
This is an example where I think, and its not always right obviously, the market is telling me something I best not ignore.
So although i had no idea what was going on the SP seemed to. (I think it was a bit before the canadian shut down RNS).
There is apart of me that just can't wait to get shot of AVCT. Its opaque as a business and you have no idea of cash burn or how test and trials are going and or timescales. And no idea what the competition is up to either.
It should be a great RNS but there is always a nagging doubt in these situations that some sort of curveball will be introduced.
Lets hope not and this time it goes to plan.
Morning Wyn, yes, I guessed 123p :-)
What is going on with Angle.. (rhetorical question). Really, I do hope / pray AVCT works and – hopefully the easy bit – has a market. Who'd have guessed that people wouldn't be buying liquid biopsies left, right and centre.
yes, thats a fair point D! 123p being the correct amount.
Hopefully all will be revealed next week. Might be a bit of FOMO from the more excitable investor today in case its a monday morning RNS.
Fingers still crossed.
Usually I am on your side (of free speech) Wyn, but I do think you might have over egged it there, with your 23p AVCT buys:
'I have over 58,000 shares in AVCT having bought a few thousand more at 23p ' :-)
Aurora, assuming you're still following wyn around, I hope you intended to write 'drivel' rather than 'dribble'...
Hi Wynn cheers mate. 2023 hopefully will make us rich :)
Got the following reply from IG regarding removal of the Eve shares from my account:
Thanks for your email.
We can't remove the shares from your account until delisting process is over. If there is some sort of takeover or residual payment, we will make the necessary changes.
For more information regarding delisted stocks, please take a look at this link:
https://www.ig.com/uk/help-and-support/corporate-events-and-dealing/corporate-action-events/what-happens-if-the-stock-i-am-trading-delists
If you have any further queries, please do not hesitate to contact us.
Regards,
Hi Yanis,
that was a good call on Harl. (and Mmag too, thanks!)
All the best
Morning guys and Happy New Year.
Yes, MMAG is doing well and I believe that the journey just started, a long way up to go from here. Not a solicitation to buy though, this is my own opinion and nothing can happen. MMAG worked well for me so far - I am currently recovering 75% of my Eve losses.
D, I had a look at ONC and if you got in now, you got in/bought at a very good level where the chances of going up are higher than the chances of going down. The weekly chart shows that the SP rebounded before from this level and th chart already shows signs of bottoming out.
We have to remember though that what looks cheap can end up looking even cheaper, but for ONC the Risk/Reward at that level is good.
Reports on AVCT are very good ( don’t own AVCT) and if successful then you will be looking at several multiples from here. There are a lot of good and respected traders/investors on Twitter that speak highly of AVCT. As always there is a risk. Risk is everywhere in the stock market though, if there was no risk we all be millionaires.
From my experience, when it comes to investing and trading I agree with Wyn; have a core long term holding which you are confident and believe in it and trade other stocks.
My biggest mistake in the past was to jump on a stock at the wrong time only for it to go down and instead of cutting losses, I allowed the losses to continue and carried on averaging down and being trapped for a long time. Averaging down for me worked on ALBA but big losses with ANGS and EVE.
When you see a good stock you need to take your time and get in at the right price. For me it worked with MMAG, I got in low and being averaging up rather than down but at the same time being very careful not to get my average close to the current SP, keep a good margin.
HARL is a good stock that we talked about before, a good one to enter but if you remember, when it was above 20p I mentioned 15p as a good entry level, when at the time 15p looked like a level well left behind. 15p now though.
Now on EVE, our painful subject. Yesterday I wrote to IG (my broker) asking them to remove EVE shares from my account. They have not responded yet. I am tired of looking at £60k+ losses with no recovery chance. Is depressing. I will even pay a fee to have them removed. :(
Hi D, I got back a couple of days ago and had a very nice time thanks.
Yes, HE1 is still there because they have the money but times scales are opaque right now. I took the money out and into AVCT , HARL and ONC.
I will probably wait either for a lower SP at HE1 (ideally 4p to buy or less), or an update on a rig being found.
Yes MMAG, is looking ok, so thats good. AVCT is worth a lot to me per penny movement.
I absolutely sympathise with your plight. I feel I have experienced exactly what you have and are, currently going through.
My "epiphany" I think was when I stopped trying to get rich quick and stopped chasing multi baggers. Just went for solid companies in growth markets. A steady 10% plus annual gain and maybe a few% in divs soons turns the ship around.
So my speculatives are a relatively small part of the overall portfolio, but I trade them more as they tend to be more volatile and give opportunity for money to be made.
But as for the AVCT BB, its a joke. The conceit of the posters who think they know whats going on is breath taking. Hopefully it all comes good but it was a high risk bet from the start with the only concrete example of what the company says as to what it produced was the LFT debacle. Not a great backdrop.
Still, we will know soon enough and fingers are very firmly crossed.
All the best to you, as always.
Hi wyn, HE1 = very frustrating. I'd temporarily bought more with the intention of selling before spud and buying back my WOSG and spectris / SXS. I think I will stick though as HE1 have such a habit of surprising. It's so tempting to buy WOSG with new cash but I CAN'T let myself... I saw your comment to Aussie P.
If AVCT suddenly do very well I may top-slice a tad and use that.
You must be glad Yanis mentioned MMAG!
(TBH, I do wonder whether I should stop this share business as I am so far down.. Pretty much all rests on AVCT for me. Everything else is too small do do much to my PF balance even if quite successful.)
Hope you had, or are still having, a good time on your travels.
IF we're both truly binned then Mr R can't be reading this :-)
well, due to HE1 going on the back burner I have released funds from there and put some into ONC as it has come off the top and to a level that has a fair chance of bouncing off back upwards.
This just go's to show that Alteri ( The investment firm that bought Bensons for beds out of administration and own it now ) do not always get it right all the time .
The firm which ploughed funds into Missguided, the online fashion retailer, in the months leading up to its insolvency is facing losses on its investment running to tens of millions of pounds.
Sky News understands that Alteri Investors, which is backed by the American private equity giant Apollo Global Management, injected a total of £50m into Missguided between December 2021 and its sale through a pre-pack administration to Mike Ashley's Frasers Group last week.
Sources said that Alteri, which was established to invest in troubled retail businesses, had invested £40m through a combination of debt and equity to acquire a controlling stake in Missguided, followed by a further £10m as it sought a new owner.
The business was sold to Mr Ashley's retail empire for £20m, although the exact sum that will be recovered by Alteri was unknown on Tuesday.
One source estimated the potential loss to Alteri at between £20m and £30m, although other Missguided assets have yet to be sold by Teneo Restructuring, the administrator.
Missguided collapsed amid rancour from suppliers who complained of bills that had remained unpaid for months.
Frasers said it intended to operate the online fashion brand on a standalone basis, adding to a string of labels, such as Jack Wills, that it has snapped up in recent years.
Missguided was founded by Nitin Passi in 2008, and became known for extraordinary and at-times controversial offers such as £1 bikinis.
Frasers swooped to buy Missguided from under the nose of Boohoo, which had been in pole position to secure a deal.
Alteri declined to comment.
Just seen this went in to administration on Monday 17th October 2022
Bensons bought some of it same day . ( No payment for shareholders )
(Alliance News) - Bed retailer Bensons for Beds on Monday confirmed that it acquired the eve Sleep PLC brand, website and related assets, shortly after eve Sleep reported that it had appointed administrators after talks to sell the company broke down.
Bensons bought the London-based mattress retailer for an undisclosed sum.
The acquisition comes weeks after Bensons secured additional investment funds from Alteri Investors to "drive its growth strategy and transformation plans."
Bensons said it intends to retain eve Sleep as a standalone brand and re-launch evesleep.co.uk later this month.
"The move to acquire the eve Sleep brand will widen Bensons' appeal and is a measure of its ambition as it continues to invest in its retail, manufacturing, digital and distribution operations," it stated.
Bensons – which operates 166 stores across the country – will add eve Sleep to its portfolio which already includes beds and mattress brands Slumberland and Staples & Co.
On early Monday, eve Sleep had said it appointed administrators.
"The likely outcome to creditors of the company is currently unknown and it is not expected that the appointment of the joint administrators will enable there to be any return to the shareholders of eve," the company said.
In September, the London-based sleep wellness brand noted a doubling of its interim pretax loss to GBP4.6 million in the six months to June 30 from GBP2.3 million the year before. Revenue dropped 16% to GBP11.6 million from GBP13.9 million. It said the negative market backdrop worsened demand for big-ticket items and homewares.
It has appointed Matthew Ingram and James Saunders, both of Kroll Advisory Ltd, as joint administrators.
Chief Executive Cheryl Calverley said: "It is heartbreaking to have to acknowledge that the best way to preserve value for creditors, those partners and suppliers that have helped us on this journey, is to now terminate the formal sale process and appoint administrators.
"Having seen the year start so brightly, with the efforts of the team over the past three years in rebuilding eve into a business fit for profitable growth coming to fruition, the frustration at the unprecedented downturn in the market over February and March was felt all the more keenly."
eve Sleep said a number of "indicative offers were received", but talks were unsuccessful.
eve Sleep floated on the stock market in 2017 with a GBP140 million valuation, but has suffered declining customer numbers and increased cost pressures in recent years.
In June, it revealed it was looking for a buyer or new investor as it warned it would miss revenue targets for the year after a period of significant consumer downturn.
eve Sleep shares are suspended.
Im still in shock CC ( and is she now indirectly employed by EVE Sleep again) and TP & the entire old EVE experienced bod simply watched the bank balance run down to near zero without alternative action bring implemented; definitely wiped out some honest shareholders by there activities - still don’t think we even got an apology!
Ha! wouldn't of that been the best!
No, we fly out on the 27th
ATB
You weren’t on the BA 6.55AM to GVA were you Wyn?!
But we are not in the alps (more beside them)
You weren’t on the
well, I will defo put it om my watchlist for 2023 so thanks for that.
But right now I am done shuffling and tweaking various stocks and levels.
My speculatives are:
HE1 (drill in the next 6-12 weeks)
AVCT. 2 announcements, 1 in Jan and 1 in feb
MMAG presumably a christmas trading update will come in Jan
HARL is a new one added but looks to be pretty rock solid so I expect to add to that as the months go by.
(The rest are largely keep and forget)
So all the very best to anyone who tunes in here and thanks for the tips.
I am off to the Alps now for a christmas/new year break (hopefully not my limbs!)
Merry Xmas all
Thanks for your valuable TA and opinions as always!
Yes certainly very interesting company, the FA is very attractive especially their exclusive US distributor Biodesix has just raised $90m to further support the commercialisation efforts of their main product from Oncimmune. Their liquid biopsy for diagnosing lung cancer has medicare coverage and yesterday announced the signings with 4 private payer insurance coverage too. Hopefully results in higher sales and royalty payments to ONC.
Hi CI,
Here is just my take.
Its been on a good run and is starting to look a bit toppy now so i would expect a pullback. The target would be about 48-49p. Assuming its just going to continue the upwards trend the next target would be 61-63p.
(My worry is the cash at hand. Have they enough money in the bank to get to profitability in 2024? If they have then it looks very good, if not then it could stall around the 48p mark?
Certainly the FA looks promising and is one to watch i think.
All the best
Hi guys, would be great to learn your opinions on the following company Oncimmune (ONC), also similar to Angle a liquid biopsy company but ONC also provides big pharma with CRO related biomarker services. Would be good to learn ur comments. Also from Wyn from a TA perspective. Thanks.
Can’t wait to see this hunk of rubbish out of my portfolio now that it is finished. Does anyone with experience in this sort of situation know how long it takes for the stock to disappear from their portfolio once and for all? I also have a small number of MCLS shares from a punt earlier in the year and they’re still there too.
It would be great if it all came good on so many fronts not least the benefit and hope it could give to so many.
I have this feeling that its the diagnostics that will be ever more highlighted and that might have the surprise element, given the this is only 1a of the 2 stage trial.
Still at least and at last, there is news, but I like you will not count any eggs just yet.
Those who have been considering getting in this is as good a price as one could reasonably expect for such a short wait (3 weeks)
I wonder if we will get a 12:30-1:30 time-wise SP bounce?
Thanks wyn. I am very glad you take the science day as a positive. I still can't allow myself to count my chickens till they actually hatch. The BB thread 'need a bigger boat' title was unfortunate too as that was the phrase the CEO of NNN used regarding his covid killing copper face masks during the pandemic, only to end up sending the machine that made them back to the manufacturer in Spain :(
I do need AVCT to do well so I will await actual unequivocal results with great anticipation!
Released an RNS this morning fore shadowing an announcement in early Jan coupled with a Science day in Feb.
This should be it, on the reasonable logic that you would not organise a science day inviting the great and the good to a trial that failed to deliver.
The SP is bobling along at the bottom of recent range and I am sure there will be a bump today but still within 30-50% of this price, looks a good place to get in now. (imo dyor etc etc)